A Dark Vector Cognition product

Item 1. Financial Statements

146K characters. Original on sec.gov ·

Item 1. Financial Statements

The 43 tables in Item 1. Financial Statements as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

STATEMENT OF EARNINGS (LOSS) (UNAUDITED)Three months ended June 30Six months ended June 30
(In millions, per-share amounts in dollars)2023202220232022
Sales of equipment$6,688$5,266$11,976$9,874
Sales of services9,1638,09617,57115,397
Insurance revenues (Note 13)8477661,6391,530
Total revenues (Note 8)16,69914,12731,18526,802
Cost of equipment sold6,9405,52912,54510,677
Cost of services sold5,4224,99610,5469,622
Selling, general and administrative expenses2,3581,8174,5004,543
Separation costs (Note 20)226148431247
Research and development455439885842
Interest and other financial charges267368536756
Insurance losses, annuity benefits and other costs (Note 13)7356691,4181,289
Non-operating benefit cost (income)(402)(101)(787)(206)
Total costs and expenses16,00113,86630,07627,770
Other income (loss) (Note 19)692(1,227)6,773(1,178)
Earnings (loss) from continuing operations before income taxes1,390(966)7,882(2,146)
Benefit (provision) for income taxes (Note 16)(333)(161)(603)(190)
Earnings (loss) from continuing operations1,058(1,127)7,279(2,336)
Earnings (loss) from discontinued operations, net of taxes (Note 2)(1,019)264239365
Net earnings (loss)39(863)7,518(1,971)
Less net earnings (loss) attributable to noncontrolling interests419(23)47
Net earnings (loss) attributable to the Company35(882)7,541(2,018)
Preferred stock dividends and other(58)(67)(204)(119)
Net earnings (loss) attributable to GE common shareholders$(23)$(949)$7,337$(2,137)
Amounts attributable to GE common shareholders
Earnings (loss) from continuing operations$1,058$(1,127)$7,279$(2,336)
Less net earnings (loss) attributable to noncontrolling interests,
continuing operations47(24)21
Earnings (loss) from continuing operations attributable to the Company1,054(1,133)7,302(2,357)
Preferred stock dividends and other(58)(67)(204)(119)
Earnings (loss) from continuing operations attributable
to GE common shareholders996(1,201)7,099(2,476)
Earnings (loss) from discontinued operations attributable
to GE common shareholders(1,019)252238339
Net earnings (loss) attributable to GE common shareholders$(23)$(949)$7,337$(2,137)
Earnings (loss) per share from continuing operations (Note 18)
Diluted earnings (loss) per share$0.91$(1.09)$6.46$(2.25)
Basic earnings (loss) per share$0.91$(1.09)$6.52$(2.25)
Net earnings (loss) per share (Note 18)
Diluted earnings (loss) per share$(0.02)$(0.86)$6.68$(1.94)
Basic earnings (loss) per share$(0.02)$(0.86)$6.74$(1.94)

2023 2Q FORM 10-Q 19

STATEMENT OF FINANCIAL POSITION (UNAUDITED)
(In millions)June 30, 2023December 31, 2022
Cash, cash equivalents and restricted cash$12,766$15,810
Investment securities (Note 3)10,8857,609
Current receivables (Note 4)14,76714,831
Inventories, including deferred inventory costs (Note 5)16,78914,891
Current contract assets (Note 9)2,0372,467
All other current assets (Note 10)1,6381,400
Assets of businesses held for sale (Note 2)1,3311,374
Current assets60,21358,384
Investment securities (Note 3)37,39236,027
Property, plant and equipment – net (Note 6)12,37412,192
Goodwill (Note 7)13,34512,999
Other intangible assets – net (Note 7)5,9546,105
Contract and other deferred assets (Note 9)5,4405,776
All other assets (Note 10)16,17215,477
Deferred income taxes (Note 16)10,35410,001
Assets of discontinued operations (Note 2)1,76131,890
Total assets$163,006$188,851
Short-term borrowings (Note 11)$1,882$3,739
Accounts payable and equipment project payables (Note 12)15,51515,399
Progress collections and deferred income (Note 9)17,14216,216
All other current liabilities (Note 15)11,62012,130
Liabilities of businesses held for sale (Note 2)1,9491,944
Current liabilities48,10849,428
Deferred income (Note 9)1,3841,409
Long-term borrowings (Note 11)19,90020,320
Insurance liabilities and annuity benefits (Note 13)38,67336,845
Non-current compensation and benefits9,94110,400
All other liabilities (Note 15)11,06711,063
Liabilities of discontinued operations (Note 2)1,56524,474
Total liabilities130,638153,938
Preferred stock (Note 17)36
Common stock (Note 17)1515
Accumulated other comprehensive income (loss) – net attributable to GE (Note 17)(3,573)(2,272)
Other capital30,42634,173
Retained earnings84,84882,983
Less common stock held in treasury(80,524)(81,209)
Total GE shareholders’ equity31,19433,696
Noncontrolling interests1,1741,216
Total equity32,36834,912
Total liabilities and equity$163,006$188,851

2023 2Q FORM 10-Q 20

STATEMENT OF CASH FLOWS (UNAUDITED)Six months ended June 30
(In millions)20232022
Net earnings (loss)$7,518$(1,971)
(Earnings) loss from discontinued operations activities(239)(365)
Adjustments to reconcile net earnings (loss) to cash from (used for) operating activities
Depreciation and amortization of property, plant and equipment719783
Amortization of intangible assets (Note 7)2991,058
(Gains) losses on purchases and sales of business interests13(19)
(Gains) losses on retained and sold ownership interests and other equity securities(6,282)1,965
Principal pension plans cost (Note 14)(556)180
Principal pension plans employer contributions(104)(100)
Other postretirement benefit plans (net)(343)(433)
Provision (benefit) for income taxes603190
Cash recovered (paid) during the year for income taxes(521)(174)
Changes in operating working capital:
Decrease (increase) in current receivables26(1,185)
Decrease (increase) in inventories, including deferred inventory costs(1,802)(1,874)
Decrease (increase) in current contract assets680400
Increase (decrease) in accounts payable and equipment project payables(22)1,111
Increase (decrease) in progress collections and current deferred income728707
Financial services derivatives net collateral/settlement3(223)
All other operating activities(256)(481)
Cash from (used for) operating activities – continuing operations465(434)
Cash from (used for) operating activities – discontinued operations(250)428
Cash from (used for) operating activities215(6)
Additions to property, plant and equipment and internal-use software(663)(549)
Dispositions of property, plant and equipment6269
Net cash from (payments for) principal businesses purchased(333)—
Dispositions of retained ownership interests4,3043,783
Net (purchases) dispositions of insurance investment securities(1,381)(1,356)
All other investing activities963(542)
Cash from (used for) investing activities – continuing operations2,9521,405
Cash from (used for) investing activities – discontinued operations(3,113)121
Cash from (used for) investing activities(161)1,525
Net increase (decrease) in borrowings (maturities of 90 days or less)(31)63
Newly issued debt (maturities longer than 90 days)10—
Repayments and other debt reductions (maturities longer than 90 days)(2,590)(2,045)
Dividends paid to shareholders(350)(294)
Redemption of GE preferred stock(3,000)—
Purchases of GE common stock for treasury(632)(370)
All other financing activities206(440)
Cash from (used for) financing activities – continuing operations(6,386)(3,086)
Cash from (used for) financing activities – discontinued operations1,992(54)
Cash from (used for) financing activities(4,394)(3,140)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash79(266)
Increase (decrease) in cash, cash equivalents and restricted cash(4,260)(1,887)
Cash, cash equivalents and restricted cash at beginning of year19,09216,859
Cash, cash equivalents and restricted cash at June 3014,83214,971
Less cash, cash equivalents and restricted cash of discontinued operations at June 301,3181,741
Cash, cash equivalents and restricted cash of continuing operations at June 30$13,514$13,231

2023 2Q FORM 10-Q 21

STATEMENT OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)Three months ended June 30Six months ended June 30
(In millions)2023202220232022
Net earnings (loss)$39$(863)$7,518$(1,971)
Less: net earnings (loss) attributable to noncontrolling interests419(23)47
Net earnings (loss) attributable to the Company$35$(882)$7,541$(2,018)
Currency translation adjustments95(760)2,481(941)
Benefit plans(173)289(2,492)529
Investment securities and cash flow hedges(474)(2,695)231(5,693)
Long-duration insurance contracts(a)2673,231(1,527)6,913
Less: other comprehensive income (loss) attributable to noncontrolling interests(2)6(5)4
Other comprehensive income (loss) attributable to the Company$(284)$58$(1,301)$804
Comprehensive income (loss)$(247)$(799)$6,212$(1,164)
Less: comprehensive income (loss) attributable to noncontrolling interests325(28)51
Comprehensive income (loss) attributable to the Company$(249)$(823)$6,239$(1,214)

(a) Represents the net after-tax change in future policy benefit reserves and related reinsurance recoverables from updating the discount rate. See Notes 1 and 13 for further information.

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)Three months ended June 30Six months ended June 30
(In millions)2023202220232022
Preferred stock issued(a)$3$6$3$6
Common stock issued$15$15$15$15
Beginning balance(3,289)(4,115)(2,272)(4,860)
Currency translation adjustments96(766)2,484(943)
Benefit plans(173)289(2,490)527
Investment securities and cash flow hedges(474)(2,695)231(5,693)
Long-duration insurance contracts2673,231(1,527)6,913
Accumulated other comprehensive income (loss)$(3,573)$(4,057)$(3,573)$(4,057)
Beginning balance30,72934,39134,17334,691
Gains (losses) on treasury stock dispositions(393)(97)(1,012)(493)
Stock-based compensation9789170180
Other changes(a)(8)(1)(2,906)4
Other capital$30,426$34,382$30,426$34,382
Beginning balance84,95582,00982,98383,286
Net earnings (loss) attributable to the Company35(882)7,541(2,018)
Dividends and other transactions with shareholders(b)(142)(155)(5,676)(296)
Retained earnings$84,848$80,972$84,848$80,972
Beginning balance(80,762)(80,673)(81,209)(81,093)
Purchases(326)(345)(638)(384)
Dispositions5641361,323594
Common stock held in treasury$(80,524)$(80,883)$(80,524)$(80,883)
GE shareholders' equity balance31,19430,43531,19430,435
Noncontrolling interests balance1,1741,2931,1741,293
Total equity balance at June 30$32,368$31,728$32,368$31,728

(a) Included $3,000 million decrease substantially all in Other capital related to our redemption of GE Series D preferred stock in the first quarter of 2023.

(b) Included $5,300 million decrease in Retained earnings reflecting a pro-rata distribution of approximately 80.1% of the shares of GE HealthCare on January 3, 2023.

2023 2Q FORM 10-Q 22

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event.

In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications.

We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. See Note 2 for further information.

The accompanying consolidated financial statements and notes are unaudited. The results reported in these financial statements should not be regarded as necessarily indicative of results that may be expected for the entire year. These financial statements should be read in conjunction with the financial statements, notes and significant accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2022 and revised portions of our 2022 Form 10-K on Form 8-K as filed on April 25, 2023.

NOTE 2. BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS. In the fourth quarter of 2022, we signed a binding agreement to sell a portion of our Steam business within our Power segment to Électricité de France S.A. (EDF). We expect to complete the sale, subject to regulatory approvals and other customary closing conditions, in the second half of 2023. Closing the transaction is expected to result in a significant gain.

In the fourth quarter of 2022, we classified our captive industrial insurance subsidiary, with assets of $534 million and liabilities of $350 million as of June 30, 2023, into held for sale. We expect to complete the sale of this business, subject to regulatory approvals, by the first half of 2024. In connection with the expected sale, in the first half of 2023, we recorded a loss of $109 million in Other income (loss) in our Statement of Earnings (Loss).

ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALEJune 30, 2023December 31, 2022
Current receivables, inventories and contract assets$568$495
Non-current captive insurance investment securities565554
Property, plant and equipment and intangible assets - net238232
Valuation allowance on disposal group classified as held for sale(126)(17)
All other assets85111
Assets of businesses held for sale$1,331$1,374
Progress collections and deferred income$1,176$1,127
Insurance liabilities and annuity benefits352358
Accounts payable, equipment project payables and other current liabilities357371
All other liabilities6487
Liabilities of businesses held for sale$1,949$1,944

DISCONTINUED OPERATIONS primarily comprise our former GE HealthCare business, our mortgage portfolio in Poland (Bank BPH), our GE Capital Aviation Services (GECAS) business, and other trailing assets and liabilities associated with prior dispositions. Results of operations, financial position and cash flows for these businesses are reported as discontinued operations for all periods presented and the notes to the financial statements have been adjusted on a retrospective basis.

GE HealthCare. On January 3, 2023, we completed the previously announced separation of our HealthCare business (the Separation), into a separate, independent, publicly traded company, GE HealthCare Technologies Inc. (GE HealthCare). The Separation was structured as a tax-free spin-off, and was achieved through GE's pro-rata distribution of approximately 80.1% of the outstanding shares of GE HealthCare to holders of GE common stock. In connection with the Separation, the historical results of GE HealthCare and certain assets and liabilities included in the Separation are reported in GE's consolidated financial statements as discontinued operations.

2023 2Q FORM 10-Q 23

We have continuing involvement with GE HealthCare primarily through a transition services agreement, through which GE and GE HealthCare continue to provide certain services to each other for a period of time following the Separation, and a trademark licensing agreement. For the six months ended June 30, 2023, we collected net cash of $453 million related to these activities.

Bank BPH. As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. In July 2023, in connection with GE and Bank BPH approving the adoption of a settlement program intended to be made available over time to Bank BPH borrowers, GE recorded an additional charge of $1,014 million, increasing total estimated losses associated with Bank BPH borrower litigation to $2,632 million as of June 30, 2023. No incremental cash contributions from GE are required in connection with this charge as the current cash balances at Bank BPH are adequate. In order to maintain appropriate regulatory capital levels, during the three and six months ended June 30, 2023, we made non-cash capital contributions in the form of intercompany loan forgiveness of $1,599 million and $1,797 million, respectively. See Note 23 for further information about the recent actions and other factors that are relevant to the estimate of total losses for borrower litigation at Bank BPH. Future changes or adverse developments could increase our estimate of total losses and potentially require future cash contributions to Bank BPH.

The Bank BPH financing receivable portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields and estimates with respect to ongoing borrower litigation. Earnings (loss) from discontinued operations included $1,014 million and $1,189 million in pre-tax charges for the three and six months ended June 30, 2023, and $201 million and $434 million in pre-tax charges for the three and six months ended June 30, 2022, respectively, primarily related to the ongoing borrower litigation. At June 30, 2023, the total portfolio had a carrying value of zero, net of a valuation allowance.

GECAS/AerCap. We have continuing involvement with AerCap, primarily through our ownership interest, ongoing sales or leases of products and services, and transition services that we provide to AerCap. For the six months ended June 30, 2023, we had direct and indirect sales of $84 million to AerCap, primarily related to engine services and sales, and purchases of $120 million from AerCap, primarily related to engine leases. We paid net cash of $171 million to AerCap related to this activity.

20232022
RESULTS OF DISCONTINUED OPERATIONS Three months ended June 30GE HealthCareBank BPH & OtherTotalGE HealthCareBank BPH & OtherTotal
Total revenues$—$—$—$4,518$—$4,518
Cost of equipment and services sold———(2,720)—(2,720)
Other income, costs and expenses—(1,040)(1,040)(1,192)(205)(1,397)
Earnings (loss) of discontinued operations before income taxes—(1,040)(1,040)606(205)401
Benefit (provision) for income taxes61117(143)3(140)
Earnings (loss) of discontinued operations, net of taxes6(1,029)(1,022)463(202)260
Gain (loss) on disposal before income taxes—44—(8)(8)
Benefit (provision) for income taxes———12—12
Gain (loss) on disposal, net of taxes—4412(8)4
Earnings (loss) from discontinued operations, net of taxes$6$(1,025)$(1,019)$474$(210)$264
20232022
RESULTS OF DISCONTINUED OPERATIONS Six months ended June 30GE HealthCareBank BPH & OtherTotalGE HealthCareBank BPH & OtherTotal
Total revenues$—$—$—$8,879$—$8,879
Cost of equipment and services sold———(5,399)—(5,399)
Other income, costs and expenses(20)(1,241)(1,261)(2,338)(455)(2,794)
Earnings (loss) of discontinued operations before income taxes(20)(1,241)(1,261)1,142(455)687
Benefit (provision) for income taxes(a)1,485101,496(293)(15)(308)
Earnings (loss) of discontinued operations, net of taxes1,466(1,231)235850(470)379
Gain (loss) on disposal before income taxes—44—(30)(30)
Benefit (provision) for income taxes———12517
Gain (loss) on disposal, net of taxes—4412(25)(14)
—
Earnings (loss) from discontinued operations, net of taxes$1,466$(1,227)$239$861$(496)$365

(a) The tax benefit for the six months ended June 30, 2023 for GE HealthCare relates to preparatory steps for the spin-off, which resulted in taxable gain offset by a deferred tax asset and the reversal of valuation allowances for capital loss carryovers utilized against a portion of the gain.

2023 2Q FORM 10-Q 24

ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONSJune 30, 2023December 31, 2022
Cash, cash equivalents and restricted cash$1,318$2,627
Current receivables133,361
Inventories, including deferred inventory costs—2,512
Goodwill—12,799
Other intangible assets - net—1,520
Contract and other deferred assets—854
Financing receivables held for sale (Polish mortgage portfolio)(a)—1,200
Property, plant and equipment - net652,379
All other assets3102,109
Deferred income taxes552,528
Assets of discontinued operations(b)$1,761$31,890
Accounts payable and equipment project payables$67$3,487
Progress collections and deferred income—2,499
Long-term borrowings—8,273
Non-current compensation and benefits365,658
All other liabilities(a)1,4624,556
Liabilities of discontinued operations(b)$1,565$24,474

(a) Included $2,017 million and $848 million of valuation allowances against Financing receivables held for sale, of which $1,776 million and $611 million related to estimated borrower litigation losses, and $856 million and $748 million in All other liabilities, related to estimated borrower litigation losses for Bank BPH’s foreign currency-denominated mortgage portfolio, as of June 30, 2023 and December 31, 2022, respectively. Accordingly, total estimated losses related to borrower litigation were $2,632 million and $1,359 million as of June 30, 2023 and December 31, 2022, respectively. As of a result of the settlement program, the valuation allowance completely offsets the financing receivables balance as of June 30, 2023.

(b) Included $130 million and $28,998 million of assets and $180 million and $23,337 million of liabilities for GE HealthCare as of June 30, 2023 and December 31, 2022, respectively.

NOTE 3. INVESTMENT SECURITIES. All of our debt securities are classified as available-for-sale and substantially all are investment-grade supporting obligations to annuitants and policyholders in our run-off insurance operations. We manage the investments in our run-off insurance operations under strict investment guidelines, including limitations on asset class concentration, single issuer exposures, asset-liability duration variances, and other factors to meet credit quality, yield, liquidity and diversification requirements associated with servicing our insurance liabilities under reasonable circumstances. This process includes consideration of various asset allocation strategies and incorporates information from several external investment advisors to improve our investment yield subject to maintaining our ability to satisfy insurance liabilities when due, as well as considering our risk-based capital requirements, regulatory constraints, and tolerance for surplus volatility. Asset allocation planning is a dynamic process that considers changes in market conditions, risk appetite, liquidity needs and other factors, which are reviewed on a periodic basis by our investment team. Our investment in GE HealthCare comprised 61.6 million shares (approximately 13.5% ownership interest) at June 30, 2023. Our investment in AerCap comprised 78.2 million ordinary shares (approximately 33.6% ownership interest) at June 30, 2023 and an AerCap senior note, for which we have adopted the fair value option. We sold our remaining shares in Baker Hughes (BKR) during the first quarter of 2023. Our GE HealthCare and AerCap investments are recorded as Equity securities with readily determinable fair values. Investment securities held within insurance entities are classified as non-current as they support the long-duration insurance liabilities.

June 30, 2023December 31, 2022
Amortized costGross unrealized gainsGross unrealized lossesEstimated fair valueAmortized costGross unrealized gainsGross unrealized lossesEstimated fair value
Equity (GE HealthCare)$—$—$—$5,003$—$—$—$—
Equity and note (AerCap)———5,882———7,403
Equity (Baker Hughes)———————207
Current investment securities$—$—$—$10,885$—$—$—$7,609
Debt
U.S. corporate$27,624$698$(1,971)$26,351$26,921$675$(2,164)$25,432
Non-U.S. corporate2,55720(270)2,3062,54818(300)2,266
State and municipal2,75974(198)2,6352,89866(241)2,722
Mortgage and asset-backed4,74010(330)4,4204,44221(290)4,173
Government and agencies1,5601(138)1,4231,1722(147)1,026
Other equity258——258408——408
Non-current investment securities$39,497$803$(2,907)$37,392$38,388$781$(3,143)$36,027

The amortized cost of debt securities excludes accrued interest of $464 million and $457 million at June 30, 2023 and December 31, 2022, respectively, which is reported in All other current assets.

2023 2Q FORM 10-Q 25

The estimated fair value of investment securities at June 30, 2023 increased since December 31, 2022, primarily due to the classification of our remaining equity interest in GE HealthCare within investment securities, new investments at Insurance, the mark-to-market effect on our equity interest in AerCap, lower market yields and tightening credit spreads, partially offset by GE HealthCare, AerCap and BKR share sales.

Total estimated fair value of debt securities in an unrealized loss position were $22,225 million and $21,482 million, of which $14,833 million and $3,275 million had gross unrealized losses of $(2,597) million and $(835) million and had been in a loss position for 12 months or more at June 30, 2023 and December 31, 2022, respectively. At June 30, 2023, the majority of our U.S. and Non-U.S. corporate securities' gross unrealized losses were in the consumer, electric, technology and energy industries. In addition, gross unrealized losses on our Mortgage and asset-backed securities included $(212) million related to commercial mortgage-backed securities (CMBS) collateralized by pools of commercial mortgage loans on real estate, and $(112) million related to asset-backed securities. The majority of our CMBS and asset-backed securities in an unrealized loss position have received investment-grade credit ratings from the major rating agencies. For our securities in an unrealized loss position, the losses are not indicative of credit losses, we currently do not intend to sell the investments, and it is not likely that we will be required to sell the investments before recovery of their amortized cost basis.

Net unrealized gains (losses) for equity securities with readily determinable fair values, which are recorded in Other income (loss) within continuing operations, were $522 million and $(1,464) million for the three months ended and $6,562 million and $(1,834) million for the six months ended June 30, 2023 and 2022, respectively.

Proceeds from debt and equity securities sales and early redemptions by issuers totaled $3,745 million and $3,474 million for the three months ended and $6,752 million and $5,423 million for the six months ended June 30, 2023 and 2022, respectively. Gross realized gains on debt securities were $26 million and $9 million for the three months ended and $38 million and $33 million for the six months ended June 30, 2023 and 2022, respectively. Gross realized losses and impairments on debt securities were $(25) million and $(11) million for the three months ended and $(46) million and $(15) million for the six months ended June 30, 2023 and 2022, respectively.

Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at June 30, 2023 are as follows:

Amortized costEstimated fair value
Within one year$931$924
After one year through five years4,7614,710
After five years through ten years5,4155,384
After ten years23,39221,697

We expect actual maturities to differ from contractual maturities because borrowers have the right to call or prepay certain obligations.

The majority of our equity securities are classified within Level 1 and the majority of our debt securities are classified within Level 2, as their valuation is determined based on significant observable inputs. Investments with a fair value of $6,394 million and $6,421 million are classified within Level 3, as significant inputs to their valuation models are unobservable at June 30, 2023 and December 31, 2022, respectively. During the six months ended June 30, 2023 and 2022, there were no significant transfers into or out of Level 3.

In addition to the equity securities described above, we hold $786 million and $614 million of equity securities without readily determinable fair values at June 30, 2023 and December 31, 2022, respectively, that are classified within non-current All other assets in our Statement of Financial Position. Fair value adjustments, including impairments, recorded in earnings were immaterial for all periods presented. These are primarily limited partnership investments in private equity, infrastructure and real estate funds that are measured at net asset value per share (or equivalent) as a practical expedient to estimated fair value and are excluded from the fair value hierarchy.

NOTE 4. CURRENT AND LONG-TERM RECEIVABLES

CURRENT RECEIVABLESJune 30, 2023December 31, 2022
Customer receivables$11,758$11,803
Revenue sharing program receivables(a)1,2501,326
Non-income based tax receivables1,1631,146
Supplier advances758691
Receivables from disposed businesses238115
Other sundry receivables362518
Allowance for credit losses(b)(764)(768)
Total current receivables$14,767$14,831

(a) Revenue sharing program receivables in Aerospace are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties.

(b) Allowance for credit losses decreased primarily due to write-offs and recoveries, partially offset by net new provisions of $21 million and foreign currency impact.

2023 2Q FORM 10-Q 26

June 30, 2023December 31, 2022
Aerospace$8,014$7,784
Renewable Energy2,3612,415
Power3,9604,229
Corporate432404
Total current receivables$14,767$14,831

Sales of customer receivables. From time to time, the Company sells current or long-term receivables to third parties in response to customer-sponsored requests or programs, to facilitate sales, or for risk mitigation purposes. The Company sold current customer receivables to third parties and subsequently collected $935 million and $953 million in the six months ended June 30, 2023 and 2022, respectively, related primarily to our participation in customer-sponsored supply chain finance programs. Within these programs, primarily in Renewable Energy and Aerospace, the Company has no continuing involvement, fees associated with the transferred receivables are covered by the customer and cash is received at the original invoice due date. Included in the sales of customer receivables in the first quarter of 2023, was $77 million in our Gas Power business, primarily for risk mitigation purposes.

LONG-TERM RECEIVABLESJune 30, 2023December 31, 2022
Long-term customer receivables(a)$405$457
Supplier advances257266
Non-income based tax receivables251213
Financing receivables14482
Sundry receivables498400
Allowance for credit losses(183)(183)
Total long-term receivables$1,372$1,236

(a) The Company sold zero and $81 million of long-term customer receivables to third parties for the six months ended June 30, 2023 and 2022, respectively, primarily in our Gas Power business for risk mitigation purposes.

NOTE 5. INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS

June 30, 2023December 31, 2022
Raw materials and work in process$10,282$9,191
Finished goods4,4593,937
Deferred inventory costs(a)2,0481,764
Inventories, including deferred inventory costs$16,789$14,891

(a) Represents cost deferral for shipped goods (such as components for wind turbine assemblies within our Renewable Energy segment) and labor and overhead costs on time and material service contracts (primarily originating in Power and Aerospace) and other costs for which the criteria for revenue recognition has not yet been met.

NOTE 6. PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES

June 30, 2023December 31, 2022
Original cost$27,212$26,641
Less accumulated depreciation and amortization(16,771)(16,303)
Right-of-use operating lease assets1,9321,854
Property, plant and equipment – net$12,374$12,192

Operating Lease Liabilities. Our consolidated operating lease liabilities, included in All other liabilities in our Statement of Financial Position, were $2,097 million and $2,089 million, as of June 30, 2023 and December 31, 2022, respectively. Expense on our operating lease portfolio, primarily from our long-term fixed leases, was $206 million and $210 million, and $401 million and $436 million, for the three and six months ended June 30, 2023 and 2022, respectively.

NOTE 7. GOODWILL AND OTHER INTANGIBLE ASSETS

GOODWILLJanuary 1, 2023AcquisitionsCurrency exchange and otherBalance at June 30, 2023
Aerospace$8,835$—$95$8,930
Renewable Energy3,201—833,284
Power144164—308
Corporate(a)818—5823
Total$12,999$164$183$13,345

(a) Corporate balance comprises our Digital business.

2023 2Q FORM 10-Q 27

We assess the possibility that a reporting unit’s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. In the second quarter of 2023, we did not identify any reporting units that required an interim impairment test. However, we continue to monitor the operating results and cash flow forecasts of our Digital reporting unit at Corporate and our Additive reporting unit in our Aerospace segment as the fair value of these reporting units were not significantly in excess of their carrying values based on the results of our most recent annual impairment test, performed in the fourth quarter of 2022. At June 30, 2023, our Digital and Additive reporting units had goodwill of $823 million and $246 million, respectively.

Intangible assets decreased $151 million during the six months ended June 30, 2023, primarily as a result of amortization, partially offset by additions of customer-related, capitalized software and patents and technology, mainly at Power and Aerospace, of $140 million. Consolidated amortization expense was $160 million and $136 million in the three months ended and $299 million and $1,058 million in the six months ended, June 30, 2023 and 2022, respectively. Included within consolidated amortization expense for the six months ended June 30, 2022 was a non-cash pre-tax impairment charge of $765 million related to intangible assets at our remaining Steam business within our Power segment, not including a related $59 million impairment charge in Property, plant and equipment. For further information on these non-cash pre-tax impairment charges, refer to our Annual Report on Form 10-K for the year ended December 31, 2022.

NOTE 8. REVENUES

EQUIPMENT & SERVICES REVENUES
Three months ended June 3020232022
EquipmentServicesTotalEquipmentServicesTotal
Aerospace$2,533$5,327$7,860$1,757$4,370$6,127
Renewable Energy3,2196303,8492,4456543,099
Power1,0733,0784,1521,1963,0064,202
Total segment revenues$6,825$9,035$15,861$5,399$8,030$13,428
Six months ended June 3020232022
EquipmentServicesTotalEquipmentServicesTotal
Aerospace$4,507$10,334$14,841$3,411$8,319$11,730
Renewable Energy5,5301,1576,6874,6181,3525,970
Power2,1755,7967,9712,1625,5427,703
Total segment revenues$12,212$17,287$29,499$10,190$15,213$25,403
REVENUESThree months ended June 30Six months ended June 30
2023202220232022
Commercial Engines & Services$5,700$4,306$10,894$8,159
Defense1,3421,0962,3592,132
Systems & Other8187251,5871,439
Aerospace$7,860$6,127$14,841$11,730
Onshore Wind$2,316$2,052$3,817$3,958
Grid Solutions equipment and services9237331,7471,401
Offshore Wind, Hydro and Hybrid Solutions6113141,122611
Renewable Energy$3,849$3,099$6,687$5,970
Gas Power$3,052$3,133$5,919$5,621
Steam Power6496911,1911,327
Power Conversion, Nuclear and other450378861755
Power$4,152$4,202$7,971$7,703
Total segment revenues$15,861$13,428$29,499$25,403
Corporate$839$699$1,686$1,399
Total revenues$16,699$14,127$31,185$26,802

REMAINING PERFORMANCE OBLIGATION. As of June 30, 2023, the aggregate amount of the contracted revenues allocated to our unsatisfied (or partially unsatisfied) performance obligations was $245,787 million. We expect to recognize revenue as we satisfy our remaining performance obligations as follows: (1) equipment-related remaining performance obligation of $53,538 million, of which 47%, 70% and 97% is expected to be satisfied within 1, 2 and 5 years, respectively; and (2) services-related remaining performance obligation of $192,249 million, of which 12%, 43%, 68% and 82% is expected to be recognized within 1, 5, 10 and 15 years, respectively, and the remaining thereafter.

2023 2Q FORM 10-Q 28

NOTE 9. CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME

Contract and other deferred assets decreased $766 million in the six months ended June 30, 2023 primarily due to a decrease in long-term service agreements, partially offset by the timing of revenue recognition ahead of billing milestones on long-term equipment contracts. Our long-term service agreements decreased primarily due to billings of $6,385 million, partially offset by revenues recognized of $5,390 million and a net favorable change in estimated profitability of $99 million at Power.

June 30, 2023AerospaceRenewable EnergyPowerCorporateTotal
Revenues in excess of billings$2,527$—$5,522$—$8,048
Billings in excess of revenues(7,608)—(1,846)—(9,454)
Long-term service agreements$(5,081)$—$3,675$—$(1,406)
Equipment and other service agreements4811,1541,5332753,443
Current contract assets$(4,600)$1,154$5,209$275$2,037
Nonrecurring engineering costs(a)2,438202—2,460
Customer advances and other(b)2,371—609—2,980
Non-current contract and other deferred assets$4,809$20$611$—$5,440
Total contract and other deferred assets$208$1,174$5,820$275$7,477
December 31, 2022
Revenues in excess of billings$2,363$—$5,403$—$7,766
Billings in excess of revenues(6,681)—(1,763)—(8,443)
Long-term service agreements$(4,318)$—$3,640$—$(677)
Equipment and other service agreements4331,0631,4042453,144
Current contract assets$(3,884)$1,063$5,044$245$2,467
Nonrecurring engineering costs(a)2,513174—2,534
Customer advances and other(b)2,519—724—3,243
Non-current contract and other deferred assets$5,032$17$728$—$5,776
Total contract and other deferred assets$1,148$1,079$5,772$245$8,244

(a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Aerospace segment, which are amortized ratably over each unit produced.

(b) Included amounts due from customers at Aerospace for the sales of engines, spare parts and services, and at Power, for the sale of services upgrades, which we collect through incremental fixed or usage-based fees from servicing the equipment under long-term service agreements.

Progress collections and deferred income increased $902 million primarily due to new collections received in excess of revenue recognition primarily at Power. Revenues recognized for contracts included in a liability position at the beginning of the year were $8,403 million and $7,232 million for the six months ended June 30, 2023 and 2022, respectively.

June 30, 2023AerospaceRenewable EnergyPowerCorporateTotal
Progress collections$5,865$5,270$5,363$134$16,632
Current deferred income18719614113510
Progress collections and deferred income$6,052$5,466$5,377$247$17,142
Non-current deferred income1,13618946141,384
Total Progress collections and deferred income$7,188$5,656$5,422$261$18,527
December 31, 2022
Progress collections$5,814$5,195$4,514$131$15,655
Current deferred income23320813107562
Progress collections and deferred income$6,047$5,404$4,527$238$16,216
Non-current deferred income1,110183104121,409
Total Progress collections and deferred income$7,157$5,586$4,632$250$17,625

NOTE 10. ALL OTHER ASSETS. All other current assets and All other assets primarily include equity method and other investments, long-term customer and sundry receivables (see Note 4), cash and cash equivalents and receivables in our run-off insurance operations and prepaid taxes and other deferred charges. All other non-current assets increased $696 million in the six months ended June 30, 2023, primarily due to an increase in equity method and other investments of $295 million, an increase in long-term receivables of $136 million, an increase in pension surplus of $126 million and an increase in Insurance cash and cash equivalents of $122 million. Insurance cash and cash equivalents was $741 million and $619 million at June 30, 2023 and December 31, 2022, respectively.

2023 2Q FORM 10-Q 29

NOTE 11. BORROWINGS

June 30, 2023December 31, 2022
Current portion of long-term borrowings
Senior notes issued by GE$195$464
Senior and subordinated notes assumed by GE1,0321,973
Senior notes issued by GE Capital5281,188
Other127115
Total short-term borrowings$1,882$3,739
Senior notes issued by GE$4,683$4,724
Senior and subordinated notes assumed by GE8,6258,406
Senior notes issued by GE Capital5,7416,289
Other851901
Total long-term borrowings$19,900$20,320
Total borrowings$21,782$24,059

The Company has provided a full and unconditional guarantee on the payment of the principal and interest on all senior and subordinated outstanding long-term debt securities issued by subsidiaries of GE Capital, our former financial services business. See Note 21 for further information about borrowings and associated hedges.

NOTE 12. ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES

June 30, 2023December 31, 2022
Trade payables$10,538$10,033
Supply chain finance programs3,2783,689
Equipment project payables(a)1,2181,236
Non-income based tax payables481441
Accounts payable and equipment project payables$15,515$15,399

(a) Primarily related to projects in our Power and Renewable Energy segments.

We facilitate voluntary supply chain finance programs with third parties, which provide participating suppliers the opportunity to sell their GE receivables to third parties at the sole discretion of both the suppliers and the third parties. Total supplier invoices paid through these third-party programs were $4,371 million and $3,493 million for the six months ended June 30, 2023 and 2022, respectively.

NOTE 13. INSURANCE LIABILITIES AND ANNUITY BENEFITS. On January 1, 2023, we adopted Accounting Standards Update No. 2018-12, Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts. The new guidance for measuring the liability for future policy benefits and related reinsurance recoverable asset was adopted on a modified retrospective basis such that those balances were adjusted to conform to the new guidance at the January 1, 2021 transition date. Refer to the revised portions of our 2022 Form 10-K on Form 8-K as filed on April 25, 2023 for more information.

Insurance liabilities and annuity benefits comprise substantially all obligations to annuitants and insureds in our run-off insurance operations. Our insurance operations (net of eliminations) generated revenues of $847 million and $766 million, profit was $64 million and $56 million and net earnings was $50 million and $46 million for the three months ended June 30, 2023 and 2022, respectively. For the six months ended June 30, 2023 and 2022, revenues were $1,639 million and $1,530 million, profit was $134 million and $162 million and net earnings was $104 million and $130 million, respectively. These operations were supported by assets of $47,386 million and $45,031 million at June 30, 2023 and December 31, 2022, respectively. A summary of our insurance liabilities and annuity benefits is presented below:

June 30, 2023Long-term careStructured settlement annuitiesLifeOther contractsTotal
Future policy benefit reserves$25,888$9,224$985$417$36,514
Investment contracts—830—8021,632
Other——176351527
Total$25,888$10,055$1,161$1,569$38,673
December 31, 2022
Future policy benefit reserves$24,256$8,860$1,040$437$34,593
Investment contracts—860—8491,708
Other——178365544
Total$24,256$9,720$1,218$1,651$36,845

2023 2Q FORM 10-Q 30

The following tables summarize balances of and changes in future policy benefits reserves.

June 30, 2023June 30, 2022
Present value of expected net premiumsLong-term careStructured settlement annuitiesLifeLong-term careStructured settlement annuitiesLife
Balance, beginning of year$4,059$—$4,828$5,652$—$6,622
Beginning balance at locked-in discount rate3,958—5,2104,451—5,443
Effect of changes in cash flow assumptions1—————
Effect of actual variances from expected experience31—(87)(168)—(3)
Adjusted beginning of year balance3,991—5,1224,283—5,440
Interest accrual105—100115—102
Net premiums collected(201)—(150)(221)—(166)
Effect of foreign currency——86——(25)
Ending balance at locked-in discount rate3,895—5,1594,177—5,351
Effect of changes in discount rate assumptions239—(162)308—(264)
Balance, end of period$4,134$—$4,997$4,485$—$5,086
Present value of expected future policy benefits
Balance, beginning of year$28,316$8,860$5,868$40,296$12,328$7,923
Beginning balance at locked-in discount rate27,0268,7906,24727,4659,0246,560
Effect of changes in cash flow assumptions(14)—————
Effect of actual variances from expected experience2610(44)(169)729
Adjusted beginning of year balance27,0388,8006,20327,2969,0306,588
Interest accrual727229119729237123
Benefit payments(630)(338)(287)(563)(333)(275)
Effect of foreign currency——91——(26)
Ending balance at locked-in discount rate27,1358,6916,12627,4618,9356,409
Effect of changes in discount rate assumptions2,887533(144)3,365683(234)
Balance, end of period$30,022$9,224$5,983$30,826$9,618$6,175
Net future policy benefit reserves$25,888$9,224$985$26,341$9,618$1,089
Less: Reinsurance recoverables, net of allowance for credit losses(186)—(34)(3,897)—(80)
Net future policy benefit reserves, after reinsurance recoverables$25,702$9,224$952$22,443$9,618$1,008

The Statement of Earnings (Loss) for the six months ended June 30, 2023 and 2022 included gross premiums or assessments of $424 million and $456 million and interest accretion of $869 million and $872 million, respectively. For the six months ended June 30, 2023 and 2022, gross premiums or assessments was substantially all related to long-term care of $246 million and $244 million and life of $166 million and $196 million, while interest accretion was substantially all related to long-term care of $621 million and $614 million and structured settlement annuities of $229 million and $237 million, respectively.

The following table provides the amount of undiscounted and discounted expected future gross premiums and expected future benefits and expenses.

June 30, 2023June 30, 2022
UndiscountedDiscounted(a)UndiscountedDiscounted(a)
Long-term care:Gross premiums$7,807$4,995$7,939$5,117
Benefit payments64,58530,02266,85030,826
Structured settlement annuities:Benefit payments19,6089,22420,3089,618
Life:Gross premiums13,6206,12514,2866,290
Benefit payments11,8505,98312,3516,175

(a) Determined using the current discount rate as of June 30, 2023 and 2022.

2023 2Q FORM 10-Q 31

The following table provides the weighted-average durations of and weighted-average interest rates for the liability for future policy benefits.

June 30, 2023June 30, 2022
Long-term careStructured settlement annuitiesLifeLong-term careStructured settlement annuitiesLife
Duration (years)(a)13.111.15.313.611.35.8
Interest accretion rate5.5%5.4%5.1%5.5%5.4%5.0%
Current discount rate5.1%5.1%5.0%5.0%4.9%4.8%

(a) Duration determined using the current discount rate as of June 30 2023 and 2022.

At June 30, 2023 and 2022, policyholders account balances totaled $1,884 million and $2,051 million, respectively. As our insurance operations are in run-off, changes in policyholder account balances for the six months ended June 30, 2023 and 2022 are primarily attributed to surrenders, withdrawals, and benefit payments of $219 million and $224 million, partially offset by net additions from separate accounts and interest credited of $134 million and $145 million, respectively. Interest on policyholder account balances is being credited at minimum guaranteed rates, primarily between 3.0% and 6.0% at both June 30, 2023 and 2022.

In the third quarter, we will complete our annual review of future policy benefit reserves cash flow assumptions, except related claim expenses which remain locked-in. If the review concludes that the assumptions need to be updated, future policy benefit reserves will be adjusted retroactively to the ASU 2018-12 transition date based on the revised net premium ratio using actual historical experience, updated cash flow assumptions, and the locked-in discount rate with the effect of those changes recognized in current period earnings.

See Note 3 for further information related to our run-off insurance operations.

NOTE 14. POSTRETIREMENT BENEFIT PLANS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories, principal pension plans, other pension plans and principal retiree benefit plans. Please refer to Note 13 to the consolidated financial statements in the revised portions of our 2022 Form 10-K on Form 8-K as filed on April 25, 2023, for further information.

The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Earnings (Loss).

PRINCIPAL PENSION PLANSThree months ended June 30Six months ended June 30
2023202220232022
Service cost for benefits earned$24$49$45$98
Expected return on plan assets(594)(785)(1,188)(1,571)
Interest cost on benefit obligations4725169461,033
Net actuarial loss amortization and other(187)352(359)715
Net periodic expense (income)(285)132(556)275
Less discontinued operations—46—95
Continuing operations – net periodic expense (income)$(285)$86$(556)$180

Principal retiree benefit plans income was $36 million and $53 million for the three months ended June 30, 2023 and 2022, respectively, and $72 million and $105 million for the six months ended June 30, 2023 and 2022, respectively. Principal retiree benefit plans income from continuing operations was $34 million and $67 million for the three months and six months ended June 30, 2022, respectively. Other pension plans income was $30 million and $99 million for the three months ended June 30, 2023 and 2022, respectively, and $59 million and $216 million for the six months ended June 30, 2023 and 2022, respectively. Other pension plans income from continuing operations was $72 million and $161 million for the three months and six months ended June 30, 2022, respectively.

We also have a defined contribution plan for eligible U.S. employees that provides employer contributions which were $103 million and $114 million for the three months ended June 30, 2023 and 2022, respectively, and $180 million and $224 million for the six months ended June 30, 2023 and 2022, respectively. Employer contributions from continuing operations were $79 million and $158 million for the three months and six months ended June 30, 2022, respectively.

NOTE 15. CURRENT AND ALL OTHER LIABILITIES. All other current liabilities and All other liabilities primarily include liabilities for customer sales allowances, equipment project and commercial liabilities, loss contracts, employee compensation and benefits, income taxes payable and uncertain tax positions, operating lease liabilities (see Note 6), environmental, health and safety remediations and product warranties (see Note 23). All other current liabilities decreased $510 million in the six months ended June 30, 2023, primarily due to employee compensation and benefit liabilities of $550 million and derivative instruments of $145 million partially offset by taxes payable of $133 million and equipment projects and other commercial liabilities of $131 million. All other liabilities increased $4 million in the six months ended June 30, 2023, primarily due to uncertain and other income taxes and related liabilities of $222 million partially offset by equipment projects and other commercial liabilities of $190 million.

2023 2Q FORM 10-Q 32

NOTE 16. INCOME TAXES. Our income tax rate was 7.7% and (8.9)% for the six months ended June 30, 2023 and 2022, respectively. The low tax rate for 2023 was primarily due to the unrealized gain on our investment in GE HealthCare, which is expected to be recovered tax-free and U.S. general business credits. We intend to dispose of our investment in a manner consistent with the tax-free treatment confirmed in our Internal Revenue Service (IRS) ruling in connection with the spin of GE HealthCare. This was partially offset by losses in foreign jurisdictions that are not likely to be utilized and separation income tax costs including disallowed expenses and valuation allowances related to the spin of GE HealthCare. The tax rate for 2022 reflects a tax provision on a pre-tax loss. The rate was negative primarily due to the net unrealized capital loss on our retained and sold ownership interests for which the loss could not be tax benefited, losses in foreign jurisdictions that are not likely to be utilized and non-tax benefited asset impairment charges.

On August 16, 2022, the U.S. enacted the Inflation Reduction Act that includes a new Corporate Alternative Minimum Tax (CAMT) based upon financial statement income, an excise tax on stock buybacks and tax incentives for energy and climate initiatives, among other provisions. The new CAMT is expected to slow but not eliminate the favorable tax impact of our deferred tax assets, resulting in higher cash tax in some years that would generate future tax benefits. The impact of CAMT will depend on our facts in each year and anticipated guidance from the U.S. Department of the Treasury. We currently do not expect to incur CAMT in 2023.

The IRS is currently auditing our consolidated U.S. income tax returns for 2016-2018.

NOTE 17. SHAREHOLDERS’ EQUITY

Three months ended June 30Six months ended June 30
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (AOCI) (Dividends per share in dollars)2023202220232022
Beginning balance$(3,505)$(4,746)$(5,893)$(4,569)
AOCI before reclasses – net of taxes of $(13), $46, $(18) and $13667(760)220(941)
Reclasses from AOCI – net of taxes of $0, $0, $(626) and $0(a)27—2,262—
AOCI95(760)2,481(941)
Less AOCI attributable to noncontrolling interests(2)6(3)2
Currency translation adjustments AOCI$(3,409)$(5,512)$(3,409)$(5,512)
Beginning balance$4,214$3,884$6,531$3,646
AOCI before reclasses – net of taxes of $12, $32, $(1) and $574197(43)151
Reclasses from AOCI – net of taxes of $(63), $51, $(657) and $106(a)(214)192(2,449)378
AOCI(173)289(2,492)529
Less AOCI attributable to noncontrolling interests——(2)2
Benefit plans AOCI$4,041$4,173$4,041$4,173
Beginning balance$(1,222)$2,174$(1,927)$5,172
AOCI before reclasses – net of taxes of $(127), $(720), $61 and $(1,521)(446)(2,714)272(5,708)
Reclasses from AOCI – net of taxes of $(3), $5, $(3) and $7(a)(28)19(41)14
AOCI(474)(2,695)231(5,693)
Investment securities and cash flow hedges AOCI$(1,696)$(521)$(1,696)$(521)
Beginning balance$(2,776)$(5,427)$(983)$(9,109)
AOCI before reclasses – net of taxes of $71, $859, $(406) and $1,8382673,231(1,527)6,913
AOCI2673,231(1,527)6,913
Long-duration insurance contracts AOCI$(2,510)$(2,196)$(2,510)$(2,196)
AOCI at June 30$(3,573)$(4,057)$(3,573)$(4,057)
Dividends declared per common share$0.08$0.08$0.16$0.16

(a)The total reclassification from AOCI included $195 million, including currency translation of $2,234 million and benefit plans of $(2,030) million, net of taxes, in first quarter of 2023 related to the spin-off of GE HealthCare.

Preferred stock. GE preferred stock shares outstanding were 2,795,444 and 5,795,444 at June 30, 2023 and December 31, 2022, respectively. We redeemed $3,000 million of GE Series D preferred stock in the first quarter of 2023. On July 25, 2023, we announced our intention to redeem the remaining outstanding shares of GE preferred stock on September 15, 2023 for expected total cash spend of approximately $2,800 million.

Common stock. GE common stock shares outstanding were 1,088,378,193 and 1,089,107,878 at June 30, 2023 and December 31, 2022, respectively. For further information on our common and preferred stock issuances, please refer to our Annual Report on Form 10-K for the year ended December 31, 2022.

2023 2Q FORM 10-Q 33

NOTE 18. EARNINGS PER SHARE INFORMATION

Three months ended June 3020232022
(Earnings for per-share calculation, shares in millions, per-share amounts in dollars)DilutedBasicDilutedBasic
Earnings (loss) from continuing operations$1,054$1,054$(1,133)$(1,133)
Preferred stock dividends and other(58)(58)(67)(67)
Earnings (loss) from continuing operations attributable to common shareholders996996(1,201)(1,201)
Earnings (loss) from discontinued operations(1,019)(1,019)252252
Net earnings (loss) attributable to GE common shareholders(23)(23)(949)(949)
Shares of GE common stock outstanding1,0891,0891,0991,099
Employee compensation-related shares (including stock options)10———
Total average equivalent shares1,0981,0891,0991,099
Earnings (loss) per share from continuing operations$0.91$0.91$(1.09)$(1.09)
Earnings (loss) per share from discontinued operations(0.93)(0.94)0.230.23
Net earnings (loss) per share(0.02)(0.02)(0.86)(0.86)
Potentially dilutive securities(b)2851
Six months ended June 3020232022
(Earnings for per-share calculation, shares in millions, per-share amounts in dollars)DilutedBasicDilutedBasic
Earnings (loss) from continuing operations$7,295$7,302$(2,357)$(2,357)
Preferred stock dividends and other(a)(204)(204)(119)(119)
Earnings (loss) from continuing operations attributable to common shareholders7,0917,098(2,476)(2,476)
Earnings (loss) from discontinued operations238238339339
Net earnings (loss) attributable to GE common shareholders7,3297,336(2,137)(2,137)
Shares of GE common stock outstanding1,0891,0891,0991,099
Employee compensation-related shares (including stock options)9———
Total average equivalent shares1,0971,0891,0991,099
Earnings (loss) per share from continuing operations$6.46$6.52$(2.25)$(2.25)
Earnings (loss) per share from discontinued operations0.220.220.310.31
Net earnings (loss) per share6.686.74(1.94)(1.94)
Potentially dilutive securities(b)3346

(a) For the six months ended June 30, 2023, included $(30) million related to excise tax on preferred share redemption.

(b) Outstanding stock awards not included in the computation of diluted earnings (loss) per share because their effect was antidilutive.

Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and, therefore, are included in the computation of earnings per share pursuant to the two-class method. For the three and six months ended June 30, 2023, application of this treatment had an insignificant effect. For the three and six months ended June 30, 2022, as a result of the loss from continuing operations, losses were not allocated to the participating securities.

NOTE 19. OTHER INCOME (LOSS)

Three months ended June 30Six months ended June 30
2023202220232022
Investment in GE HealthCare realized and unrealized gain (loss)$(214)$—$5,879$—
Investment in and note with AerCap realized and unrealized gain (loss)572(1,071)378(2,807)
Investment in Baker Hughes realized and unrealized gain (loss)—(459)101,056
Gains (losses) on retained and sold ownership interests$358$(1,530)$6,266$(1,751)
Other net interest and investment income (loss)15554341147
Licensing and royalty income912912586
Equity method income687769115
Other items20142(28)224
Total other income (loss)$692$(1,227)$6,773$(1,178)

Our investment in GE HealthCare comprises 61.6 million shares (approximately 13.5% ownership interest) at June 30, 2023. During the six months ended June 30, 2023, we received total proceeds of $2,192 million from the disposition of GE HealthCare shares. Our investment in AerCap comprises 78.2 million ordinary shares (approximately 33.6% ownership interest) at June 30, 2023 and an AerCap senior note. During the six months ended June 30, 2023, we received total proceeds of $1,898 million from the sale of AerCap shares. During the first quarter of 2023, we received proceeds of $216 million from the sale of Baker Hughes shares and have now fully monetized our position.

2023 2Q FORM 10-Q 34

NOTE 20. RESTRUCTURING CHARGES AND SEPARATION COSTS

RESTRUCTURING AND OTHER CHARGES. This table is inclusive of all restructuring charges in our segments and at Corporate, and the charges are shown below for the business where they originated. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate.

Three months ended June 30Six months ended June 30
RESTRUCTURING AND OTHER CHARGES2023202220232022
Workforce reductions$92$5$157$19
Plant closures & associated costs and other asset write-downs382412151
Acquisition/disposition net charges and other14162725
Total restructuring and other charges$144$46$305$94
Cost of equipment/services$29$16$65$43
Selling, general and administrative expenses1152924054
Other (income) loss———(3)
Total restructuring and other charges$144$46$305$94
Aerospace$4$5$7$10
Renewable Energy76614112
Power19333967
Corporate4621185
Total restructuring and other charges$144$46$305$94
Restructuring and other charges cash expenditures$155$85$293$211

An analysis of changes in the liability for restructuring follows:

Three months ended June 30Six months ended June 30
2023202220232022
Balance at beginning of period$976$710$977$825
Additions852217131
Payments(97)(70)(184)(185)
Effect of foreign currency and other(2)(22)(2)(31)
Balance at June 30(a)$963$640$963$640

(a) Includes actuarial determined post-employment severance benefits reserve of $360 million and $328 million as of June 30, 2023 and 2022, respectively. Also includes $64 million reserve in discontinued operations related to a GE technology contract which is indemnified by GE HealthCare as of June 30, 2023.

For the three and six months ended June 30, 2023, restructuring and other initiatives primarily included exit activities related to the restructuring program announced in the fourth quarter of 2022 reflecting lower Corporate shared-service and footprint needs as a result of the GE HealthCare spin-off. It also includes exit activities associated with the plan announced in the fourth quarter of 2022 to undertake a restructuring program across our businesses planned to be part of GE Vernova, primarily reflecting the selectivity strategy to operate in fewer markets and to simplify and standardize product variants at Renewable Energy. We recorded total charges of $144 million and $305 million, consisting of $59 million and $134 million, primarily in non-cash impairment, accelerated depreciation and other charges, not reflected in the table above, and $85 million and $171 million primarily in employee workforce reduction charges, which are reflected in the table above in the three and six months ended June 30, 2023, respectively. We incurred $155 million and $293 million in cash outflows related to restructuring actions, primarily for employee severance payments and contract terminations in the three and six months ended June 30, 2023, respectively.

For the three and six months ended June 30, 2022, restructuring and other initiatives primarily included exit activities at our Power business related to our new coal build wind-down actions announced in the third quarter of 2021, which included the exit of certain product lines, closing certain manufacturing and office facilities, and workforce reduction programs. We recorded total charges of $46 million and $94 million, consisting of $24 million and $63 million primarily in non-cash impairment, accelerated depreciation and other charges, not reflected in the table above, and $22 million and $31 million primarily in employee workforce reduction charges, which are reflected in the table above in the three and six months ended June 30, 2022, respectively. We incurred $85 million and $211 million in cash outflows related to restructuring actions, primarily for employee severance payments in the three and six months ended June 30, 2022, respectively.

SEPARATION COSTS. In November 2021, the company announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy. As a result of this plan, we have incurred and expect to continue to incur separation, transition, and operational costs, which will depend on specifics of the transactions.

2023 2Q FORM 10-Q 35

For the three and six months ended June 30, 2023, we incurred pre-tax separation expense of $226 million and $431 million, paid $372 million and $576 million in cash, respectively, primarily related to employee costs, professional fees, costs to establish certain stand-alone functions and information technology systems, and other transformation and transaction costs to transition to three stand-alone public companies. These costs are presented as separation costs in our consolidated Statement of Earnings (Loss). In addition, we incurred $34 million net tax benefit and $22 million of net tax expense, including taxes associated with planned legal entity restructuring and changes to indefinite reinvestment of foreign earnings in the three and six months ended June 30, 2023, respectively.

For the three and six months ended June 30, 2022, respectively, we incurred pre-tax separation costs of $148 million and $247 million, paid $20 million and $23 million in cash, and recognized $15 million and $39 million of net tax expense related to separation activities.

As discussed in Note 2, GE completed the separation of its HealthCare business into a separate, independent publicly traded company, GE HealthCare Technologies Inc. As a result, pre-tax separation costs specifically identifiable to GE HealthCare are now reflected in discontinued operations. We incurred $1 million and $21 million in pre-tax costs for the three and six months ended June 30, 2023, respectively, recognized $4 million of tax benefits for the six months ended June 30, 2023, and spent $55 million and $140 million in cash for the three and six months ended June 30, 2023, respectively.

NOTE 21. FINANCIAL INSTRUMENTS. The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2.

June 30, 2023December 31, 2022
Carrying amount (net)Estimated fair valueCarrying amount (net)Estimated fair value
AssetsLoans and other receivables$2,329$2,196$2,557$2,418
LiabilitiesBorrowings (Note 11)$21,782$20,805$24,059$22,849
Investment contracts (Note 13)1,6321,6771,7081,758

Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash and equivalents, investment securities and derivative financial instruments.

DERIVATIVES AND HEDGING. Our policy requires that derivatives are used solely for managing risks and not for speculative purposes. We use derivatives to manage currency risks related to foreign exchange, and interest rate and currency risk between financial assets and liabilities, and certain equity investments and commodity prices.

FAIR VALUE OF DERIVATIVESJune 30, 2023December 31, 2022
Gross NotionalAll other assetsAll other liabilitiesGross NotionalAll other assetsAll other liabilities
Currency exchange contracts$4,784$147$129$5,112$132$146
Derivatives accounted for as hedges$4,784$147$129$5,112$132$146
Currency exchange contracts$62,266$1,139$1,056$51,885$946$1,082
Other contracts7001591590119714
Derivatives not accounted for as hedges$62,966$1,298$1,071$52,786$1,143$1,095
Gross derivatives$67,750$1,445$1,200$57,898$1,275$1,241
Netting and credit adjustments$(926)$(925)$(821)$(820)
Net derivatives recognized in statement of financial position$519$275$454$420

FAIR VALUE HEDGES. As of June 30, 2023, all fair value hedges were terminated due to exposure management actions, including debt maturities. Gains (losses) associated with the terminated hedging relationships will continue to amortize into interest expense until the hedged borrowings mature. The cumulative amount of hedging adjustments of $1,216 million (all on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $8,956 million. At June 30, 2022, the cumulative amount of hedging adjustments of $1,801 million (all on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $15,290 million. The cumulative amount of hedging adjustments was primarily recorded in long-term borrowings.

2023 2Q FORM 10-Q 36

CASH FLOW HEDGES AND NET INVESTMENT HEDGES
Gain (loss) recognized in AOCIThree months ended June 30Six months ended June 30
2023202220232022
Cash flow hedges(a)$21$(110)$49$(157)
Net investment hedges(b)(68)183(130)294

(a) Primarily related to currency exchange contracts.

(b) The carrying value of foreign currency debt designated as net investment hedges was $4,710 million and $3,311 million as of June 30, 2023 and 2022, respectively. The total reclassified from AOCI into earnings was zero for both the three months and six months ended June 30, 2023 and 2022.

Changes in the fair value of cash flow hedges are recorded in AOCI and recorded in earnings in the period in which the hedged transaction occurs. The total amount in AOCI related to cash flow hedges of forecasted transactions was a $15 million loss as of June 30, 2023. We expect to reclassify $31 million of loss to earnings in the next 12 months contemporaneously with the earnings effects of the related forecasted transactions. As of June 30, 2023, the maximum term of derivative instruments that hedge forecasted transactions was approximately 12 years.

The table below presents the effects of hedges and resulting gains (losses) of our derivative financial instruments in the Statement of Earnings (Loss):

Three months ended June 30, 2023Three months ended June 30, 2022
RevenuesInterest ExpenseSG&AOther(a)RevenuesInterest ExpenseSG&AOther(a)
$16,699$267$2,358$13,054$14,127$368$1,817$9,298
Cash flow hedges$4$(4)$—$11$—$(7)$—$(36)
Fair value hedges$(7)
Non-hedging derivatives (b)$(1)$—$175$(69)$1$—$(349)$(29)
Six months ended June 30, 2023Six months ended June 30, 2022
RevenuesInterest ExpenseSG&AOther(a)RevenuesInterest ExpenseSG&AOther(a)
$31,185$536$4,500$29,864$26,802$756$4,543$19,120
Cash flow hedges$5$(6)$—$9$4$(13)$—$(68)
Fair value hedges$(16)
Non-hedging derivatives (b)$—$—$290$(127)$2$—$(454)$(95)

(a) Amounts are inclusive of cost of sales and other income (loss).

(b) SG&A was primarily driven by hedges of deferred incentive compensation, and hedges of remeasurement of monetary assets and liabilities.

COUNTERPARTY CREDIT RISK. Our exposures to counterparties were $391 million and $306 million at June 30, 2023 and December 31, 2022, respectively. Counterparties' exposures to our derivative liability were $216 million and $365 million at June 30, 2023 and December 31, 2022, respectively.

NOTE 22. VARIABLE INTEREST ENTITIES. In our Statement of Financial Position, we have assets of $306 million and $401 million and liabilities of $200 million and $206 million at June 30, 2023 and December 31, 2022, respectively, in consolidated Variable Interest Entities (VIEs). These entities were created to help our customers facilitate or finance the purchase of GE equipment and services and have no features that could expose us to losses that would significantly exceed the difference between the consolidated assets and liabilities.

Our investments in unconsolidated VIEs were $6,238 million and $5,917 million at June 30, 2023 and December 31, 2022, respectively. Of these investments, $1,415 million and $1,481 million were owned by EFS, comprising equity method investments, primarily renewable energy tax equity investments, at June 30, 2023 and December 31, 2022, respectively. In addition, $4,607 million and $4,219 million were owned by our run-off insurance operations, primarily comprising equity method investments at June 30, 2023 and December 31, 2022, respectively. The increase in investments in unconsolidated VIEs in our run-off insurance operations reflects strategic initiatives to invest in higher-yielding asset classes. Our maximum exposure to loss in respect of unconsolidated VIEs is increased by our commitments to make additional investments in these entities described in Note 23.

2023 2Q FORM 10-Q 37

NOTE 23. COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES

COMMITMENTS. We had total investment commitments of $4,054 million at June 30, 2023. The commitments primarily comprise investments by our run-off insurance operations in investment securities and other assets of $3,975 million and included within these commitments are obligations to make investments in unconsolidated VIEs of $3,719 million. See Note 22 for further information.

As of June 30, 2023, in our Aerospace segment, we have committed to provide financing assistance of $2,583 million of future customer acquisitions of aircraft equipped with our engines.

GUARANTEES. Indemnification agreements - Discontinued Operations. Following the Separation of GE HealthCare on January 3, 2023, GE has remaining performance and bank guarantees on behalf of its former HealthCare business. Under the Separation Distribution Agreement (SDA) entered into by the Company and GE HealthCare in connection with the Separation, GE HealthCare is obligated to use reasonable best efforts to replace GE as the guarantor on or terminate all such credit support instruments. Until such termination or replacement, in the event of non-fulfillment of contractual obligations by the relevant obligor(s), GE could be obligated to make payments under the applicable instruments. Under the SDA, GE HealthCare is obligated to reimburse and indemnify GE for any such payments. As of June 30, 2023, GE’s maximum aggregate exposure under such credit support instruments was $54 million. Most of these guarantees are not expected to remain in effect as of December 31, 2023. GE also has obligations under the Transition Services Agreement to indemnify GE HealthCare for certain of its technology costs of $56 million, which are expected to be incurred by GE HealthCare within the first year following the Separation and are fully reserved, and under the Tax Matters Agreement to indemnify GE HealthCare for certain tax costs of $47 million, which are fully reserved. In addition, we have provided specific indemnities to other buyers of assets of our business that, in the aggregate, represent a maximum potential claim of $726 million with related reserves of $75 million.

Indemnification agreements – Continuing Operations. GE has obligations under the Tax Matters Agreement to indemnify GE HealthCare for certain tax costs and other indemnifications of $39 million, which are fully reserved. In addition, we have $504 million of other indemnification commitments, including representations and warranties in sales of business assets, for which we recorded a liability of $72 million.

For information on credit support agreements, see our Annual Report on Form 10-K for the year ended December 31, 2022.

PRODUCT WARRANTIES. We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. The liability for product warranties was $1,955 million and $1,960 million at June 30, 2023 and December 31, 2022, respectively.

LEGAL MATTERS. The following information supplements and amends the discussion of Legal Matters in Note 24 to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2022 and Note 23 to the consolidated financial statements in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023; refer to those discussions for information about previously reported legal matters that are not updated below. In the normal course of our business, we are involved from time to time in various arbitrations, class actions, commercial litigation, investigations and other legal, regulatory or governmental actions, including the significant matters described below that could have a material impact on our results of operations. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties and other factors that may have a material effect on the outcome. For these matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated.

Alstom legacy legal matters. In 2015, we acquired the Steam Power, Renewables and Grid businesses from Alstom, which prior to our acquisition were the subject of significant cases involving anti-competitive activities and improper payments. We had reserves of $421 million and $455 million at June 30, 2023 and December 31, 2022, respectively, for legal and compliance matters related to the legacy business practices that were the subject of cases in various jurisdictions. Allegations in these cases relate to claimed anti-competitive conduct or improper payments in the pre-acquisition period as the source of legal violations or damages. Given the significant litigation and compliance activity related to these matters and our ongoing efforts to resolve them, it is difficult to assess whether the disbursements will ultimately be consistent with the reserve established. The estimation of this reserve may not reflect the full range of uncertainties and unpredictable outcomes inherent in litigation and investigations of this nature, and at this time we are unable to develop a meaningful estimate of the range of reasonably possible additional losses beyond the amount of this reserve. Factors that can affect the ultimate amount of losses associated with these and related matters include the way cooperation is assessed and valued, prosecutorial discretion in the determination of damages, formulas for determining disgorgement, fines or penalties, the duration and amount of legal and investigative resources applied, political and social influences within each jurisdiction, and tax consequences of any settlements or previous deductions, among other considerations. Actual losses arising from claims in these and related matters could exceed the amount provided.

2023 2Q FORM 10-Q 38

Baker Hughes shareholder lawsuit. As previously reported by Baker Hughes, in March 2019, two derivative lawsuits were filed in the Delaware Court of Chancery naming as defendants GE, directors of Baker Hughes (including former members of GE’s Board of Directors and current and former GE executive officers) and Baker Hughes (as nominal defendant), and the court issued an order consolidating these two actions (the Schippnick case). The complaint as amended in May 2019 alleged, among other things, that GE and the Baker Hughes directors breached their fiduciary duties, and that GE was unjustly enriched by entering into transactions and agreements related to GE's sales of approximately 12% of its ownership interest in Baker Hughes in November 2018. The complaint sought declaratory relief, disgorgement of profits, an award of damages, pre- and post-judgment interest and attorneys’ fees and costs. In May 2019, the plaintiffs voluntarily dismissed their claims against the directors who were members of the Baker Hughes Conflicts Committee and a former Baker Hughes director. In October 2019, the Court denied the remaining defendants’ motions to dismiss, except with respect to the unjust enrichment claim against GE, which was dismissed. In November 2019, the defendants filed their answer to the complaint, and a special litigation committee of the Baker Hughes Board of Directors moved for an order staying all proceedings in this action pending completion of the committee's investigation of the allegations and claims asserted in the complaint. In October 2020, the special litigation committee filed a report with the Court recommending that the derivative action be terminated. In January 2021, the special committee filed a motion to terminate the action. In April 2023, the Court granted the special committee’s motion to terminate the action.

GE Retirement Savings Plan class actions. Four putative class action lawsuits have been filed regarding the oversight of the GE RSP, and those class actions have been consolidated into a single action in the U.S. District Court for the District of Massachusetts. The consolidated complaint names as defendants GE, GE Asset Management, current and former GE and GE Asset Management executive officers and employees who served on fiduciary bodies responsible for aspects of the GE RSP during the class period. Like similar lawsuits that have been brought against other companies in recent years, this action alleges that the defendants breached their fiduciary duties under the Employee Retirement Income Security Act (ERISA) in their oversight of the GE RSP, principally by retaining five proprietary funds that plaintiffs allege were underperforming as investment options for plan participants and by charging higher management fees than some alternative funds. The plaintiffs seek unspecified damages on behalf of a class of GE RSP participants and beneficiaries from September 26, 2011 through the date of any judgment. In August and December 2018, the court issued orders dismissing one count of the complaint and denying GE's motion to dismiss the remaining counts. In September 2022, both GE and the plaintiffs filed motions for summary judgment on the remaining claims, and oral arguments on the motions have been scheduled for August 2023.

Bank BPH. As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. For several years, GE has observed an increase in the number of lawsuits being brought against Bank BPH and other banks in Poland by current and former borrowers, and we expect this to continue in future reporting periods.

In July 2023, GE took actions to significantly reduce exposure to future losses at Bank BPH. GE and Bank BPH have approved the adoption of a settlement program intended to be made available over time to Bank BPH borrowers. GE also converted the entirety of its $1,599 million parent company loan to equity in the bank in order to maintain appropriate regulatory capital levels. In connection with the foregoing, GE recorded an additional charge of $1,014 million, increasing total estimated losses associated with Bank BPH borrower litigation to $2,632 million as of June 30, 2023 compared to $1,540 million as of March 31, 2023.

No incremental cash contributions from GE are required in connection with the charge as the current cash balances at Bank BPH are adequate.

The estimate of total losses for borrower litigation at Bank BPH as of June 30, 2023 accounts for the costs of payments to borrowers who we estimate will participate in the settlement program, as well as estimates of litigation with other borrowers where remedies can often exceed the value of the current loan balance, and represents our best estimate of the total losses we expect to incur over time. However, there are a number of factors that could affect the estimate in the future, including: potentially significant judicial decisions or binding resolutions by the European Court of Justice (ECJ) or the Polish Supreme Court, including a ruling by the ECJ in June 2023 that could significantly increase the cost to banks of loans invalidated by Polish courts and encourage more borrower lawsuits; the impact of any such decisions or resolutions on how Polish courts will interpret and apply the law in particular cases; the receptivity of borrowers over time to Bank BPH’s and other banks’ settlement offers; the ability of banks, including Bank BPH, to recover from borrowers the original principal amount of loans invalidated by Polish courts. In addition, there is continued uncertainty arising from investigations by the Polish Office of Competition and Consumer Protection (UOKiK), particularly UOKiK's investigation into the adequacy of disclosure of foreign exchange risk by banks (including Bank BPH) and the legality under Polish law of unlimited foreign exchange risk on customers. While we are unable at this time to develop a meaningful estimate of reasonably possible losses beyond the amount currently recorded, future changes related to any of the foregoing or in Bank BPH’s settlement approach, or other adverse developments such as actions by regulators, legislators or other governmental authorities (including UOKiK), could increase our estimate of total losses and potentially require future cash contributions to Bank BPH. See Note 2 for further information.

2023 2Q FORM 10-Q 39

ENVIRONMENTAL, HEALTH AND SAFETY MATTERS. As previously reported, in 2000, GE and the Environmental Protection Agency (EPA) entered into a consent decree relating to PCB cleanup of the Housatonic River in Massachusetts. Following the EPA’s release in September 2015 of an intended final remediation decision, GE and the EPA engaged in mediation and the first step of the dispute resolution process contemplated by the consent decree. In October 2016, the EPA issued its final decision pursuant to the consent decree, which GE and several other interested parties appealed to the EPA’s Environmental Appeals Board (EAB). The EAB issued its decision in January 2018, affirming parts of the EPA’s decision and granting relief to GE on certain significant elements of its challenge. The EAB remanded the decision back to the EPA to address those elements and reissue a revised final remedy, and the EPA convened a mediation process with GE and interested stakeholders. In February 2020, the EPA announced an agreement between the EPA and many of the mediation stakeholders, including GE, concerning a revised Housatonic River remedy. Based on the mediated resolution, the EPA solicited public comment on a draft permit and issued the final revised permit effective in January 2021. In March 2021, two local environmental advocacy groups filed a joint petition to the EAB challenging portions of the revised permit; in February 2022, the EAB denied the petition, and the permit became effective in March 2022. In May 2022, the two environmental advocacy groups petitioned the U.S. Court of Appeals for the First Circuit to review the EPA’s final permit, and in June 2023, the Court heard oral arguments on that petition. As of June 30, 2023, and based on its assessment of current facts and circumstances and its defenses, GE believes that it has recorded adequate reserves to cover future obligations associated with the proposed final remedy. For further information about environmental, health and safety matters, see the revised portions of our 2022 Form 10-K on Form 8-K as filed on April 25, 2023.

Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits